News

We actively communicate on our business, services and technical capabilities. Use the resources on this page to browse through recent news, to subscribe to our news services or to meet us at one of our forthcoming events.

Ad hoc announcements pursuant to Art. 53 LR

PolyPeptide with record revenue growth of 43% in H2 2023 versus H1 2023; operational improvements yielding increased profitability and cash flow

12 Mar 2024 - Baar, 12 March 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients, today announced its results for […]

Read more
Media releases

PolyPeptide signs scientific collaboration agreement

31 Oct 2023 - Strasbourg, 31 October 2023 – PolyPeptide today announced the signing of a collaboration agreement with the Peptide Sciences Laboratory of the University of KwaZulu-Natal (UKZN) in […]

Read more
Media releases

PolyPeptide secures revolving credit facility

2 Oct 2023 - Baar, 2 October 2023 – PolyPeptide Group AG (SIX: PPGN) announces the signing of a revolving credit facility agreement with Credit Suisse, Danske Bank and Zürcher […]

Read more
Ad hoc announcements pursuant to Art. 53 LR

Transformational progress taking shape, profitability impacted by rapid expansion – appointment of Marc Augustin as new CFO

15 Aug 2023 - Baar, 15 August 2023 – PolyPeptide today announced its results for H1 2023, updated guidance for 2023 and the appointment of its new CFO: Reported results […]

Read more
Ad hoc announcements pursuant to Art. 53 LR

PolyPeptide delivers revenue of around EUR 132 million for H1 – expects net loss for H1 and full year 2023

13 Jul 2023 - Baar, July 13th, 2023 – PolyPeptide Group AG (SIX: PPGN) achieves H1 2023 revenue of around EUR 132 million driven by strong momentum in its peptide […]

Read more
Expert views

Quality Assessment and Minimizing Racemization, Precipitation, and Radical-Induced Side Reactions by TBEC/Oxyma Couplings in an Environmentally Sensible Solvent

23 Jun 2023 - Elevating 1-tert-Butyl-3-ethylcarbodiimide (TBEC) as a Reagent for Sustainable Peptide Synthesis: Quality Assessment and Minimizing Racemization, Precipitation, and Radical-Induced Side Reactions by TBEC/Oxyma Couplings in an Environmentally […]

Read more
Expert views

Trending topics at PolyPeptide

1 Jun 2023 - We are proud to share some of the recent recorded presentations from our experts at TIDES USA 2023: “Raw material control strategy” Eran Benjamin, Global Director […]

Read more
Media releases

PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs

9 May 2023 - Baar (Switzerland) and Düsseldorf (Germany), 9 May 2023 – PolyPeptide, a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients (APIs), and Numaferm, a German […]

Read more
Business news

PolyPeptide launches new “Innovation Lab”

8 May 2023 - Strasbourg, France, 8 May 2023 – To support its strategic ambitions, PolyPeptide relocated and expanded its Innovation Lab in Strasbourg. The Group’s central innovation team under […]

Read more